GSK India Global Services Private Limited operates as a core hub for a global biopharma giant whose business model is built on high-value, high-stakes data: proprietary vaccine research, clinical trial datasets, and specialty medicine intellectual property. The threat model isn't theoretical. It's the constant pressure of protecting decades of R&D investment, patient health information, and the operational integrity of a supply chain that must be seamless and untampered. The attack surface spans global IT/OT infrastructure, from laboratory systems to manufacturing controls.
The security team's domain is pharmaceutical-grade. This means defending the integrity of drug development pipelines, securing the digital infrastructure that supports vaccine R&D and specialty medicine production, and ensuring compliance in a heavily regulated industry. You're not just watching endpoints; you're safeguarding the core assets of a company with a stated goal to impact the health of 2.5 billion people this decade. Operational reliability is a clinical requirement, not an IT metric.
With a global footprint and headquarters in London, the India operations are a critical node in a security posture that must be both technically rigorous and scaled to enterprise-level complexity. The work sits at the intersection of advanced persistent threats targeting valuable IP and the zero-tolerance operational demands of healthcare.
